* Colgate Duraphat 5000 ppm high fluoride toothpaste for patients ≥ 16 years and over at increased caries risk.
^ Colgate Duraphat 2800 ppm high fluoride toothpaste for patients ≥ 10 years and over at increased caries risk.
# vs a regular fluoride toothpaste with 1100 ppm fluoride.
** Compared to generic 5000 ppm high fluoride toothpaste.
^^ Colgate UK Consumer Survey on Cosmetic Toothpaste. 504 participants. Feb 2020.
† for 4 weeks or more.
*** These five therapeutic areas include asthma, type 2 diabetes, hypertension, schizophrenia and statins for primary prevention and secondary prevention of cardiovascular diseases.
†† Usage as according to the summary of product characteristics.
& YouGov Omnibus for Colgate® UK, data on file June 2015. Claim applies only to the Colgate® brand.
1 Biesbrock AR, Gerlach RW, Bollmer BW, Faller RV, Jacobs SA, Bartizek RD: Relative anti-caries efficacy of 1100, 1700, 2200, and 2800 ppm fluoride ion in a sodium fluoride dentifrice over 1 year. Community Dent Oral Epidemiol 29 (2001),382-389.
2 Baysan A, Lynch E, Ellwood R, Davies R, Petersson L, Borsboom P: Reversal of primary root caries using dentifrices containing 5000 and 1100 ppm fluoride. Caries Res. 35 (2001), 41-46
3 Ekstrand KR, Poulsen JE, Hede B, Twetman S, Qvist V, Ellwood RP: A randomized clinical trial of the anti-caries efficacy of 5000 compared to 1450 ppm fluoridated toothpaste on root caries lesions in elderly disabled nursing home residents. Caries Res 47 (2013), 391-398
4 Schirrmeister JF, Gebrande J, Altenburger MJ, Hellwig E: Effect of dentifrice containing 5000 ppm fluoride on non-cavitated fissure carious lesions in vivo after 2 weeks. Am J Dent 20 (2007), 212-216.
5 Ekstrand KR, Ekstrand ML, Lykkeaa J, Bardow A, Twetman S: Whole-saliva fluoride levels and saturation indices in people aged 65+ during use of four different toothpaste regimens. Caries Res 49 (2015), 489-498
6 Data on file. Preference Survey. January 2020 (n=82).
7 https://www.podiatrytoday.com/blogged/what-difference-between-adherence-versus-compliance-patient-behavior.
8 US Surgeon General Koop CE. Keynote address. In: Improving Medication Compliance. Proceedings of a Symposium. Reston, Va. National Pharmaceutical Council. 1985.
9 Dept. Health and Rt. Hon. Earl Howe. 8 August 2011. Action on medicine wastage and improving medicine use. https://www.gov.uk/government/news/action-on-medicine-wastage-and-improving-medicine-use.
10 Evaluation of the scale, cause and costs of waste medicine. Final report. York health Economics Consortium and School of Pharmacy, University of London. November 2010.